Centers for Metabolic Disease Research, Cardiovascular Research, & Thrombosis Research, Departments of Pharmacology, Lewis Katz School of Medicine at Temple University ,and Shanxi Medical University, Taiyuan, 030001, China.
Centers for Metabolic Disease Research, Cardiovascular Research, & Thrombosis Research, Departments of Pharmacology, Lewis Katz School of Medicine at Temple University,Philadelphia, PA, 19140, U.S.A.
Front Biosci (Landmark Ed). 2018 Jan 1;23(2):348-387. doi: 10.2741/4595.
We mined novel uremic toxin (UT) metabolomics/gene databases, and analyzed the expression changes of UT receptors and UT synthases in chronic kidney disease (CKD) and cardiovascular disease (CVD). We made the following observations: 1) UTs represent only 1/80 of human serum small-molecule metabolome; 2) Some UTs are increased in CKD and CVD; 3) UTs either induce or suppress the expression of inflammatory molecules; 4) The expression of UT genes is significantly modulated in CKD patients, and coronary artery disease (CAD) patients; 5) The expression of UT genes is upregulated by caspase-1 and TNF-alpha pathways but is inhibited in regulatory T cells. These results demonstrate that UTs are selectively increased, and serve as danger signal-associated molecular patterns (DAMPs) and homeostasis-associated molecular patterns (HAMPs) that modulate inflammation. These results also show that some UT genes are upregulated in CKD and CAD via caspase-1/inflammatory cytokine pathways, rather than by purely passive accumulation.
我们挖掘了新的尿毒症毒素 (UT) 代谢组学/基因数据库,并分析了 UT 受体和 UT 合成酶在慢性肾脏病 (CKD) 和心血管疾病 (CVD) 中的表达变化。我们有如下观察结果:1)UT 仅占人体血清小分子代谢组的 1/80;2)一些 UT 在 CKD 和 CVD 中增加;3)UT 诱导或抑制炎症分子的表达;4)UT 基因在 CKD 患者和冠心病 (CAD) 患者中的表达受到显著调节;5)UT 基因的表达受半胱天冬酶-1 和 TNF-α通路上调,但在调节性 T 细胞中受到抑制。这些结果表明,UT 选择性增加,作为危险信号相关的分子模式 (DAMPs) 和与稳态相关的分子模式 (HAMPs),调节炎症。这些结果还表明,一些 UT 基因在 CKD 和 CAD 中通过半胱天冬酶-1/炎症细胞因子途径上调,而不是单纯的被动积累。